Lacrimal Drainage Resistance Study
LDRS
1 other identifier
observational
40
1 country
1
Brief Summary
Epiphora, or uncontrolled tearing of the eyes, represents a common presenting complaint of patients seen by ophthalmologists. Epiphora may be due to non-obstructive causes, such as tear hypersecretion or functional tear pump failure, or obstructive causes. Functional tear pump failure may result from malposition of the eyelids, such as an abnormal out-turning (ectropion) or in-turning (entropion) of the eyelid. Currently methods to diagnose partial nasolacrimal duct obstruction are purely qualitative in nature. Our research goal is to quantitatively measure the pressure generated during conventional probing and irrigation (P\&I), and to measure the resistance to irrigation of the nasolacrimal drainage system. The investigators will measure the pressure generated during conventional P\&I using a disposable in-line pressure transducer. In addition, the investigators will use a syringe pump to deliver a constant flow rate of saline through a nasolacrimal cannula and measure the steady state irrigation pressure using the in-line transducer and digital pressure monitor. Resistance can be directly calculated from the known flow rate and pressure measurements. The investigators will compare both the pressure generated during P\&I and the lacrimal drainage resistance between patients with lacrimal drainage obstruction and controls patients with no obstruction (functional tear pump failure) as determined by clinical exam. Clinical applications for measuring lacrimal drainage resistance include quantifying partial nasolacrimal duct obstruction, guiding the choice of surgical procedure, and determining the success of lacrimal drainage procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
May 13, 2011
CompletedFirst Posted
Study publicly available on registry
January 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedFebruary 19, 2015
February 1, 2015
5.8 years
May 13, 2011
February 17, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Lacrimal drainage resistance
one-time clinical measurement
Secondary Outcomes (1)
Pressure generated during nasolacrimal duct irrigation
one-time clinical measurement
Study Arms (2)
Obstructed nasolacrimal drainage group
This group of patients is clinically identified as having epiphora due to an obstruction of the lacrimal drainage system.
Ectropion group
This group of patients is clinically determined to have functional epiphora due to ectropion and a patent lacrimal drainage system.
Eligibility Criteria
Patients presenting to the oculoplastics service with epiphora.
You may qualify if:
- Adult patients (18 years and older) who present for evaluation of epiphora due to obstructed causes, and control patients who present for evaluation of epiphora due to non-obstructed functional causes, who have been recommended for traditional probing and irrigation
You may not qualify if:
- Active infection
- Punctal stenosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic Cole Eye Institute
Cleveland, Ohio, 44195, United States
Related Publications (6)
Kuchar A, Steinkogler FJ. Antegrade balloon dilatation of nasolacrimal duct obstruction in adults. Br J Ophthalmol. 2001 Feb;85(2):200-4. doi: 10.1136/bjo.85.2.200.
PMID: 11159486BACKGROUNDMills DM, Meyer DR. Acquired nasolacrimal duct obstruction. Otolaryngol Clin North Am. 2006 Oct;39(5):979-99, vii. doi: 10.1016/j.otc.2006.07.002.
PMID: 16982258BACKGROUNDPerry JD, Maus M, Nowinski TS, Penne RB. Balloon catheter dilation for treatment of adults with partial nasolacrimal duct obstruction: a preliminary report. Am J Ophthalmol. 1998 Dec;126(6):811-6. doi: 10.1016/s0002-9394(98)00278-5.
PMID: 9860005BACKGROUNDStanley CF, Masri FA. Instrument to test patency of lacrimal drainage system. J Clin Eng. 1991 Jan-Feb;16(1):57-60. doi: 10.1097/00004669-199101000-00014.
PMID: 10109831BACKGROUNDTsirbas A, Davis G, Wormald PJ. Mechanical endonasal dacryocystorhinostomy versus external dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg. 2004 Jan;20(1):50-6. doi: 10.1097/01.IOP.0000103006.49679.23.
PMID: 14752311BACKGROUNDTucker SM, Linberg JV, Nguyen LL, Viti AJ, Tucker WJ. Measurement of the resistance to fluid flow within the lacrimal outflow system. Ophthalmology. 1995 Nov;102(11):1639-45. doi: 10.1016/s0161-6420(95)30815-9.
PMID: 9098256BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julian D Perry, MD
Cleveland Clinic Cole Eye Institute
- PRINCIPAL INVESTIGATOR
Brian Costin, MD
The Cleveland Clinic
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
May 13, 2011
First Posted
January 11, 2013
Study Start
April 1, 2009
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
February 19, 2015
Record last verified: 2015-02